Results 31 to 40 of about 10,004,929 (375)

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2022
Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of gastric cancers are adenocarcinomas, which are typically classified based on anatomic location and histologic type.
J. Ajani, T. D’amico, D. Bentrem, J. Chao, David Cooke, Carlos Corvera, P. Das, P. Enzinger, T. Enzler, P. Fanta, F. Farjah, H. Gerdes, M. Gibson, S. Hochwald, W. Hofstetter, D. Ilson, R. Keswani, Sunnie S Kim, L. Kleinberg, S. Klempner, J. Lacy, Quan P. Ly, K. Matkowskyj, M. Mcnamara, M. Mulcahy, D. Outlaw, Haeseong Park, K. Perry, J. Pimiento, G. Poultsides, S. Reznik, R. Roses, V. Strong, Stacey Su, Hanlin L. Wang, G. Wiesner, C. Willett, D. Yakoub, H. Yoon, Nicole R Mcmillian, L. Pluchino   +40 more
semanticscholar   +1 more source

Genetics in clinical oncology [PDF]

The Indian Journal of Pediatrics, 1982
This is the first book to provide a thorough grounding in the applications of genetics to cancer medicine, enabling the clinician to convey to patients and their families an understanding of the genetic nature of cancer, and to provide them with accurate advice.
openaire   +2 more sources

Citation analysis of Canadian psycho-oncology and supportive care researchers [PDF]

, 2013
Purpose: The purpose of this study was to conduct a historical review of psycho-oncology and supportive care research in Canada using citation analysis and to review the clinical impact of the research conducted by the most highly cited researchers ...
Crooks, Dauna, Hack, Thomas, Kepron, Emma, Plohman, James   +3 more
core   +1 more source

Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2022
The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, invasive
W. Gradishar, M. Moran, J. Abraham, R. Aft, D. Agnese, K. Allison, B. Anderson, H. Burstein, H. Chew, C. Dang, A. Elias, S. Giordano, M. Goetz, L. Goldstein, S. Hurvitz, S. Isakoff, R. Jankowitz, S. Javid, J. Krishnamurthy, M. Leitch, J. Lyons, J. Mortimer, Sameer A. Patel, L. Pierce, L. Rosenberger, H. Rugo, Amy M. Sitapati, K. Smith, Mary Lou Smith, H. Soliman, E. Stringer-Reasor, M. Telli, J. Ward, K. Wisinski, Jessica S. Young, J. Burns, Rashmi Kumar   +36 more
semanticscholar   +1 more source

Study protocol: addressing evidence and context to facilitate transfer and uptake of consultation recording use in oncology: a knowledge translation implementation study [PDF]

, 2011
Background: The time period from diagnosis to the end of treatment is challenging for newly diagnosed cancer patients. Patients have a substantial need for information, decision aids, and psychosocial support.
Degner, Lesley F, Grenier, Debjani, Hack, Thomas F, Ruether, J Dean, Weir, Lorna M   +4 more
core   +2 more sources

American Society of Clinical Oncology

Definitions, 2020
distinct and molecular subtypes lymphoma (DLBCL): (GCB) lymphoma, clinical and clinical trials identifying who in a high-risk Stomatitis occurs in approximately 65% of patients who are being treated with everolimus. Dr.
Walter Alexander
semanticscholar   +1 more source

Publication of original research in urologic journals - a neglected orphan? [PDF]

, 2012
The pathophysiologic mechanisms behind urologic disease are increasingly being elucidated. The object of this investigation was to evaluate the publication policies of urologic journals during a period of progressively better understanding and management
Ackermann, Hanns, Blaheta, Roman A., Haferkamp, Axel, Jüngel, Eva, Makarević, Jasmina, Mani, Jens, Nelson, Karen   +6 more
core   +2 more sources

Increasing equitable access to telehealth oncology care in the COVID‐19 National Emergency: Creation of a telehealth task force

Cancer Medicine, 2023
Introduction Telehealth (TH) utilization in cancer care prior to COVID‐19 was variable. Research highlights disparities in access determined by socioeconomic factors including education, income, race, and age.
Brooke Worster, Lauren Waldman, Gregory Garber, Tingting Zhan, AnaMaria Lopez, Olivia Trachtenberg, Nathan Handley, Kristin L. Rising, Valerie Csik, Amy Leader   +9 more
doaj   +1 more source

Adjuvant therapy for early uterine high-grade leiomyosarcoma [PDF]

, 2019
TO THE EDITOR: The article by Hensley et al1 recently published in Journal of Clinical Oncology was interesting, even if apparently negative (Gynecology Oncology Group [GOG]-0277 randomized phase III trial). The study investigated the activity and safety
Panici, P. B., Tomao, F., Tomao, S.
core   +1 more source

Pharmacogenomic Identification of c-Myc/Max-Regulated Genes Associated with Cytotoxicity of Artesunate towards Human Colon, Ovarian and Lung Cancer Cell Lines

Molecules, 2010
Development of novel therapy strategies is one of the major pressing topics of clinical oncology to overcome drug resistance of tumors. Artesunate (ART) is an anti-malarial drug, which also exerts profound cytotoxic activity towards cancer cells.
Serkan Sertel, Tolga Eichhorn, Christian H. Simon, Peter K. Plinkert, Steven W. Johnson, Thomas Efferth   +5 more
doaj   +1 more source